Trial Profile
Pharmacological treatment of ADHD [Attention-deficit hyperactivity disorder] in young children
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 Oct 2023
Price :
$35
*
At a glance
- Drugs Atomoxetine (Primary)
- Indications Attention-deficit hyperactivity disorder
- Focus Therapeutic Use
- 21 Mar 2011 Primary endpoint 'Attention Deficit Hyperactivity Disorder Rating Scale' has been met according to results published in Pediatrics.
- 21 Mar 2011 Status changed from recruiting to completed as published in Pediatrics.
- 21 Mar 2011 Results published in Pediatrics.